The Trump administration will give countries a proposed tariff rate based on their own rates, non-tariff trade barriers and ...
Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that ... ITI-1284-ODT-SL in Phase 2 ...
Optum Rx has eliminated prior authorization for almost 70 drugs for chronic diseases, about 10% of its overall pharmacy prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results